Literature DB >> 20642177

Too poor for transplant: finance and insurance issues in transplant ethics.

Kyle Alexander Laurentine1, Katrina A Bramstedt.   

Abstract

CONTEXT: Donor organs are a scarce gift. Additionally, transplantation is very expensive and the United States lacks universal health insurance for all citizens. These facts combine to make personal finance and insurance some of the criteria for wait listing at US transplant centers. Previous research has shown that the poor and the uninsured (as well as women and nonwhites) are less likely to receive a transplant. Living donor candidates are also limited by the US insurance system.
OBJECTIVE: To determine the effect of finance and insurance variables on access to transplant and living donation.
DESIGN: A qualitative descriptive study of ethics consultation data contained in a research registry approved by the institutional review board at California Pacific Medical Center. SETTING AND PARTICIPANTS: This study analyzes research registry data from a large community hospital in Northern California that serves patients from California, Oregon, and Nevada. The registry data are derived from transplant ethics consultations occurring between January 1, 2007, and June 30, 2009. MAIN OUTCOME MEASURE: This study explores the restriction of access to transplantation and of participation in living donation.
RESULTS: More than a quarter of all transplant ethics consultation reports described the restriction of transplant-related treatment for reasons rooted in finance or insurance. Individuals on the recipient side and on the donor side were hindered with regard to access. Insurance status and personal ability to pay significantly affect access to transplantation in the United States, and this theme is a frequent feature of ethics consultations at California Pacific Medical Center.

Entities:  

Mesh:

Year:  2010        PMID: 20642177     DOI: 10.1177/152692481002000213

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.065


  6 in total

1.  Direct Delivery of Kidney Transplant Education to Black and Low-Income Patients Receiving Dialysis: A Randomized Controlled Trial.

Authors:  Amy D Waterman; John Devin Peipert; Anna-Michelle McSorley; Christina J Goalby; Jennifer L Beaumont; Leanne Peace
Journal:  Am J Kidney Dis       Date:  2019-06-19       Impact factor: 8.860

2.  Concerns regarding the financial aspects of kidney transplantation: perspectives of pre-transplant patients and their family members.

Authors:  Sumitha Ganji; Patti L Ephraim; Jessica M Ameling; Tanjala S Purnell; LaPricia L Lewis-Boyer; L Ebony Boulware
Journal:  Clin Transplant       Date:  2014-08-25       Impact factor: 2.863

3.  County socioeconomic characteristics and pediatric renal transplantation outcomes.

Authors:  Rebecca Miller; Clifford Akateh; Noelle Thompson; Dmitry Tumin; Don Hayes; Sylvester M Black; Joseph D Tobias
Journal:  Pediatr Nephrol       Date:  2018-03-12       Impact factor: 3.714

4.  Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.

Authors:  Kathleen J Ramos; Jenna Sykes; Sanja Stanojevic; Xiayi Ma; Joshua S Ostrenga; Aliza Fink; Bradley S Quon; Bruce C Marshall; Albert Faro; Kristofer Petren; Alexander Elbert; Christopher H Goss; Anne L Stephenson
Journal:  Chest       Date:  2021-04-17       Impact factor: 10.262

5.  Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States.

Authors:  Lauren D Nephew; Kelly Mosesso; Archita Desai; Marwan Ghabril; Eric S Orman; Kavish R Patidar; Chandrashekhar Kubal; Mazen Noureddin; Naga Chalasani
Journal:  JAMA Netw Open       Date:  2020-10-01

6.  Should the poor have no medicines to cure? A study on the association between social class and social security among the rural migrant workers in urban China.

Authors:  Ming Guan
Journal:  Int J Equity Health       Date:  2017-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.